Clinical trials
Completed Observational Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
555 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 5 |
| 2002 | 7 |
| 2003 | 8 |
| 2004 | 16 |
| 2005 | 9 |
| 2006 | 15 |
| 2007 | 16 |
| 2008 | 25 |
| 2009 | 19 |
| 2010 | 22 |
| 2011 | 25 |
| 2012 | 20 |
| 2013 | 32 |
| 2014 | 33 |
| 2015 | 37 |
| 2016 | 30 |
| 2017 | 33 |
| 2018 | 25 |
| 2019 | 28 |
| 2020 | 36 |
| 2021 | 29 |
| 2022 | 20 |
| 2023 | 23 |
| 2024 | 14 |
| 2025 | 8 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 555 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 15 |
| Bayer | 15 |
| Memorial Sloan Kettering Cancer Center | 14 |
| National Cancer Institute (NCI) | 14 |
| IRCCS San Raffaele | 10 |
| University Health Network, Toronto | 10 |
| Ipsen | 9 |
| Mayo Clinic | 8 |
| Chinese University of Hong Kong | 7 |
| Duke University | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 555 |
| Breast Neoplasms | 58 |
| Neoplasms | 35 |
| Lung Neoplasms | 34 |
| Colorectal Neoplasms | 26 |
| Colonic Neoplasms | 19 |
| Ovarian Neoplasms | 17 |
| Kidney Neoplasms | 16 |
| Prostatic Hyperplasia | 16 |
| Pancreatic Neoplasms | 15 |
Trials
Showing 1 to 25 of 555. Each trial links to its page on Pharma Observatory.
455 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.